Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ludwig G Strauss

Showing results (11-20 of 65) with videos related to

Pageof 7
Sort By:
Hellenic Journal of Nuclear Medicine|September 26, 2008
A new approach for the development of tracers: data base screening and in silico modeling for the identification of new ligands for SSTR2Caixia Cheng, Leyun Pan, Antonia Dimitrakopoulou-Strauss, et al.
Immunopharmacology and Immunotoxicology|July 12, 2013
Effects of omalizumab on eosinophil cationic peptide, 25-hydroxyvitamin-D, IL-1β and sCD200 in cases of Samter's syndrome: 36 months follow-upArzu Didem Yalcin, Seçil Uçar, Saadet Gumuslu, et al.
Hellenic Journal of Nuclear Medicine|November 26, 2009
Quantitative, dynamic 18F-FDG-PET for the evaluation of soft tissue sarcomas: relation to differential diagnosis, tumor grading and prediction of prognosisShinichi Okazumi, Antonia Dimitrakopoulou-Strauss, Matthias H M Schwarzbach, et al.
Hellenic Journal of Nuclear Medicine|August 9, 2007
A recent application of fluoro-18-deoxyglucose positron emission tomography, treatment monitoring with a mammalian target of rapamycin inhibitor: an example of a patient with a desmoplastic small round cell tumorAntonia Dimitrakopoulou-Strauss, Peter Hohenberger, Philipp Ströbel, et al.
Expert Opinion on Biological Therapy|July 26, 2013
Omalizumab is effective in treating severe asthma in patients with severe cardiovascular complications and its effects on sCD200, d-dimer, CXCL8, 25-hydroxyvitamin D and IL-1β levelsArzu Didem Yalcin, Aykut Cilli, Atil Bisgin, et al.
Thescientificworldjournal|June 16, 2012
Correlation of dynamic PET and gene array data in patients with gastrointestinal stromal tumorsLudwig G Strauss, Antonia Dimitrakopoulou-Strauss, Dirk Koczan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 16, 2011
Shortened acquisition protocols for the quantitative assessment of the 2-tissue-compartment model using dynamic PET/CT 18F-FDG studiesLudwig G Strauss, Leyun Pan, Caixia Cheng, et al.
Hellenic Journal of Nuclear Medicine|March 14, 2012
Incidental detection and monitoring of spontaneous recovery of sarcoidosis via fluorine-18-fluoroethyl-choline positron emission tomography/computed tomographyMustafa Takesh, Uwe Haberkorn, Ludwig G Strauss, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 15, 2011
Parametric images via dynamic 18F-fluorodeoxyglucose positron emission tomographic data acquisition in predicting midterm outcome of liver metastases secondary to gastrointestinal stromal tumoursDimitris J Apostolopoulos, Antonia Dimitrakopoulou-Strauss, Peter Hohenberger, et al.
Clinical Nuclear Medicine|August 21, 2009
Prediction of progression-free survival in patients with multiple myeloma following anthracycline-based chemotherapy based on dynamic FDG-PETAntonia Dimitrakopoulou-Strauss, Martin Hoffmann, Raoul Bergner, et al.
Pageof 7

Showing results (11-20 of 65) with videos related to

Sort By:
Pageof 7
Hellenic Journal of Nuclear Medicine|September 26, 2008
A new approach for the development of tracers: data base screening and in silico modeling for the identification of new ligands for SSTR2Caixia Cheng, Leyun Pan, Antonia Dimitrakopoulou-Strauss, et al.
Immunopharmacology and Immunotoxicology|July 12, 2013
Effects of omalizumab on eosinophil cationic peptide, 25-hydroxyvitamin-D, IL-1β and sCD200 in cases of Samter's syndrome: 36 months follow-upArzu Didem Yalcin, Seçil Uçar, Saadet Gumuslu, et al.
Hellenic Journal of Nuclear Medicine|November 26, 2009
Quantitative, dynamic 18F-FDG-PET for the evaluation of soft tissue sarcomas: relation to differential diagnosis, tumor grading and prediction of prognosisShinichi Okazumi, Antonia Dimitrakopoulou-Strauss, Matthias H M Schwarzbach, et al.
Hellenic Journal of Nuclear Medicine|August 9, 2007
A recent application of fluoro-18-deoxyglucose positron emission tomography, treatment monitoring with a mammalian target of rapamycin inhibitor: an example of a patient with a desmoplastic small round cell tumorAntonia Dimitrakopoulou-Strauss, Peter Hohenberger, Philipp Ströbel, et al.
Expert Opinion on Biological Therapy|July 26, 2013
Omalizumab is effective in treating severe asthma in patients with severe cardiovascular complications and its effects on sCD200, d-dimer, CXCL8, 25-hydroxyvitamin D and IL-1β levelsArzu Didem Yalcin, Aykut Cilli, Atil Bisgin, et al.
Thescientificworldjournal|June 16, 2012
Correlation of dynamic PET and gene array data in patients with gastrointestinal stromal tumorsLudwig G Strauss, Antonia Dimitrakopoulou-Strauss, Dirk Koczan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 16, 2011
Shortened acquisition protocols for the quantitative assessment of the 2-tissue-compartment model using dynamic PET/CT 18F-FDG studiesLudwig G Strauss, Leyun Pan, Caixia Cheng, et al.
Hellenic Journal of Nuclear Medicine|March 14, 2012
Incidental detection and monitoring of spontaneous recovery of sarcoidosis via fluorine-18-fluoroethyl-choline positron emission tomography/computed tomographyMustafa Takesh, Uwe Haberkorn, Ludwig G Strauss, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 15, 2011
Parametric images via dynamic 18F-fluorodeoxyglucose positron emission tomographic data acquisition in predicting midterm outcome of liver metastases secondary to gastrointestinal stromal tumoursDimitris J Apostolopoulos, Antonia Dimitrakopoulou-Strauss, Peter Hohenberger, et al.
Clinical Nuclear Medicine|August 21, 2009
Prediction of progression-free survival in patients with multiple myeloma following anthracycline-based chemotherapy based on dynamic FDG-PETAntonia Dimitrakopoulou-Strauss, Martin Hoffmann, Raoul Bergner, et al.
Pageof 7